HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong-Sheng Pei Selected Research

Disks Large Homolog 4 Protein

12/2009Overexpression of the PDZ1 domain of PSD-95 diminishes ischemic brain injury via inhibition of the GluR6.PSD-95.MLK3 pathway.
12/2009Inhibition of cerebral ischemia/reperfusion-induced injury by adenovirus expressed C-terminal amino acids of GluR6.
12/2005N-Acetylcysteine inhibit the translocation of mixed lineage kinase-3 from cytosol to plasma membrane during transient brain ischemia in rat hippocampus.
8/2004Postsynaptic density protein 95 antisense oligodeoxynucleotides inhibits the activation of MLK3 and JNK3 via the GluR6.PSD-95.MLK3 signaling module after transient cerebral ischemia in rat hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong-Sheng Pei Research Topics

Disease

42Neoplasms (Cancer)
12/2021 - 01/2006
21Ischemia
01/2012 - 08/2004
17Brain Ischemia (Cerebral Ischemia)
01/2012 - 02/2005
10Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 03/2005
8Brain Injuries (Brain Injury)
12/2009 - 02/2005
7Melanoma (Melanoma, Malignant)
03/2015 - 08/2010
5Carcinogenesis
01/2022 - 01/2014
5Neoplasm Metastasis (Metastasis)
01/2020 - 11/2016
4Stomach Neoplasms (Stomach Cancer)
11/2020 - 01/2014
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 01/2014
4Kidney Neoplasms (Kidney Cancer)
01/2009 - 01/2006
3Colorectal Neoplasms (Colorectal Cancer)
07/2020 - 10/2014
3Glioma (Gliomas)
10/2015 - 03/2011
3Stroke (Strokes)
12/2009 - 02/2006
3Reperfusion Injury
01/2009 - 05/2007
2Hepatocellular Carcinoma (Hepatoma)
08/2021 - 05/2015
2Genomic Instability
04/2018 - 08/2016
2Lung Neoplasms (Lung Cancer)
01/2018 - 06/2013
2Astrocytoma (Pilocytic Astrocytoma)
10/2017 - 03/2011
2Breast Neoplasms (Breast Cancer)
10/2017 - 01/2014
2Carcinoma (Carcinomatosis)
03/2015 - 08/2013
2Transient Ischemic Attack
09/2007 - 08/2004
1Necrosis
01/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Bone Resorption
01/2018
1Inflammation (Inflammations)
01/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
10/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2015

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2000
11Phosphotransferases (Kinase)IBA
08/2021 - 02/2005
6Biological ProductsIBA
01/2019 - 10/2014
6Small Interfering RNA (siRNA)IBA
08/2015 - 01/2006
6InterleukinsIBA
03/2015 - 06/2010
6JNK Mitogen-Activated Protein KinasesIBA
01/2012 - 02/2005
5p21-Activated KinasesIBA
01/2021 - 07/2014
5Peptides (Polypeptides)IBA
01/2012 - 02/2006
4COP9 Signalosome ComplexIBA
01/2019 - 08/2015
4Biomarkers (Surrogate Marker)IBA
01/2019 - 09/2016
4Caspase 3 (Caspase-3)IBA
03/2015 - 05/2006
4Serine (L-Serine)FDA Link
12/2010 - 10/2005
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2010 - 06/2005
4Kainic Acid (Kainate)IBA
03/2010 - 12/2005
4Disks Large Homolog 4 ProteinIBA
12/2009 - 08/2004
4pyrazolanthroneIBA
05/2007 - 02/2005
3Indicators and Reagents (Reagents)IBA
07/2021 - 01/2017
3RNA (Ribonucleic Acid)IBA
11/2020 - 04/2006
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 12/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2015 - 08/2008
3IntegrinsIBA
02/2012 - 10/2011
3AntioxidantsIBA
01/2009 - 01/2006
3OligodeoxyribonucleotidesIBA
01/2009 - 08/2004
3Neuroprotective AgentsIBA
06/2008 - 06/2005
2HMGB1 Protein (HMG1)IBA
01/2020 - 01/2018
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2018 - 08/2009
2MicroRNAs (MicroRNA)IBA
11/2016 - 05/2014
2Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
03/2015 - 08/2008
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2014 - 08/2013
2Troglitazone (Rezulin)FDA Link
01/2014 - 08/2013
2CytokinesIBA
01/2012 - 10/2011
2arginyl-glycyl-aspartic acidIBA
01/2012 - 10/2011
2GluK2 Kainate ReceptorIBA
12/2010 - 12/2009
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
12/2010 - 10/2005
2Messenger RNA (mRNA)IBA
11/2010 - 07/2006
2Mitogen-Activated Protein Kinase Kinase Kinase 11IBA
12/2009 - 12/2005
2Oxygen (Dioxygen)IBA
12/2009 - 11/2009
2Glucose (Dextrose)FDA LinkGeneric
12/2009 - 11/2009
2LipidsIBA
08/2009 - 03/2005
2N-Methylaspartate (NMDA)IBA
02/2006 - 06/2005
2Acetylcysteine (Siran)FDA LinkGeneric
01/2006 - 12/2005
16-methyladenineIBA
01/2022
1Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA
12/2021
1CateninsIBA
08/2021
1Sorafenib (BAY 43-9006)FDA Link
08/2021
1AntiportersIBA
01/2021
1Cystine (L-Cystine)IBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1Lipid PeroxidesIBA
01/2021
1Carrier Proteins (Binding Protein)IBA
11/2020
1UbiquitinIBA
11/2020
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
11/2020
1MethyltransferasesIBA
11/2020
1Long Noncoding RNAIBA
07/2020
1Cathepsin LIBA
01/2019
1Nucleosomes (Nucleosome)IBA
01/2018
1SteroidsIBA
01/2018
1Hormones (Hormone)IBA
01/2018
1ChromatinIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Tartrate-Resistant Acid PhosphataseIBA
01/2018
1Small Untranslated RNAIBA
10/2017
1Monomeric GTP-Binding ProteinsIBA
01/2017
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2016
1SaltsIBA
01/2016
1Tacrolimus Binding Proteins (FKBP)IBA
10/2015

Therapy/Procedure

21Therapeutics
12/2021 - 03/2005
2Intraventricular Infusions
01/2012 - 12/2005
2Drug Therapy (Chemotherapy)
03/2011 - 08/2010
1Heterologous Transplantation (Xenotransplantation)
11/2020